In tumor cells, lncRNA MEG3 inhibits the proliferation and metastasis of breast, gastric, liver and pancreatic cancer cells by activating the p53 signaling pathway (Chen et al., 2016; Hu et al., 2016; Wei and Wang, 2017; Huang et al., 2022). Here, MEG3 is linked to pancreatic neoplasm.